FDMT Competitors & Alternatives
Compare 4D Molecular Therapeutics Inc with similar stocks in the same industry
Biotechnology
FDMT
Main Stock$11.73
Tradestie Score
58
Market Cap
$407.71M
Revenue Growth
216.6%
Analyst Upside
+140.6%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.12
|
$552.46M | - | 57 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.72
|
$540.97M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.83
|
$529.35M | 6.4 | 64 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.16
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$35.77
|
$505.12M | 1.7 | 64 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$92.94
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.95
|
$474.20M | 26.7 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.47
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$20.58
|
$463.20M | - | 56 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.69
|
$457.09M | - | 62 | Compare |
More FDMT Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry